EULAV Asset Management Buys 5,765 Shares of Humana Inc. $HUM

Key Points

• EULAV Asset Management purchased 5,765 Humana shares worth approximately $2.2 million during the third quarter. Institutional investors collectively own 92.38% of the company.
• Analysts maintain a generally positive outlook, with a consensus rating of “Moderate Buy” and an average price target of $453.30; several firms recently raised their targets.
• Humana exceeded quarterly earnings and revenue expectations, reporting $7.61 in adjusted EPS and $40.89 billion in revenue. The company also declared a quarterly dividend of $0.885 per share, representing a 0.8% yield.

EULAV Asset Management purchased a new stake in Humana Inc. (NYSE:HUM - Free Report) during the third quarter, according to its most recent filing with the SEC. The firm purchased 5,765 shares of the insurance provider's stock, valued at approximately $2,200,000.

Several other large investors have also recently made changes to their positions in HUM. BlackRock Inc. bought a new stake in Humana during the second quarter valued at about $4,138,160,000. Pzena Investment Management LLC bought a new position in Humana in the second quarter worth about $1,749,014,000. Assenagon Asset Management S.A. raised its holdings in Humana by 20,126.8% in the third quarter. Assenagon Asset Management S.A. now owns 1,255,479 shares of the insurance provider's stock worth $479,053,000 after purchasing an additional 1,249,272 shares in the last quarter. Legal & General Group Plc bought a new position in Humana in the second quarter worth about $329,760,000. Finally, Barrow Hanley Mewhinney & Strauss LLC purchased a new stake in shares of Humana during the second quarter valued at about $314,922,000. 92.38% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on HUM. Barclays raised their price target on shares of Humana from $515.00 to $582.00 and gave the company an "overweight" rating in a report on Friday, October 9th. JPMorgan Chase & Co. boosted their price objective on shares of Humana from $316.00 to $393.00 and gave the stock a "neutral" rating in a research note on Monday, August 10th. Mizuho increased their target price on shares of Humana from $468.00 to $495.00 and gave the company an "outperform" rating in a research report on Tuesday, October 13th. Guggenheim raised their target price on shares of Humana from $269.00 to $471.00 and gave the company a "buy" rating in a research note on Thursday, July 30th. Finally, Oppenheimer lifted their price target on shares of Humana from $475.00 to $525.00 and gave the stock an "outperform" rating in a report on Monday, October 12th. Twenty-one investment analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $453.30.

Humana Trading Down 0.1%

Humana stock opened at $421.56 on Monday. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.74 and a current ratio of 1.74. The stock has a market cap of $50.62 billion, a PE ratio of 39.88, a price-to-earnings-growth ratio of 2.60 and a beta of 0.74. The stock has a 50-day moving average of $397.95 and a two-hundred day moving average of $352.25. Humana Inc. has a one year low of $163.11 and a one year high of $456.50.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, topping analysts' consensus estimates of $7.27 by $0.34. Humana had a return on equity of 11.20% and a net margin of 0.88%. The business had revenue of $40.89 billion for the quarter, compared to analyst estimates of $40.58 billion. During the same quarter in the previous year, the firm earned $6.27 earnings per share. The company's revenue was up 26.2% on a year-over-year basis. On average, research analysts anticipate that Humana Inc. will post 9.03 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 27th. Investors of record on Friday, October 30th will be issued a $0.8850 dividend. The ex-dividend date of this dividend is Friday, October 30th. This represents a $3.54 dividend on an annualized basis and a yield of 0.8%. Humana's dividend payout ratio is presently 33.49%.

Humana Profile

Humana Inc is a health and well-being company that provides insurance products and health care services in the United States and Puerto Rico. The company's primary business is government-sponsored health coverage, particularly Medicare Advantage plans for older adults, along with Medicare prescription drug plans, Medicaid coverage and certain commercial health insurance products.

Humana also operates CenterWell, its health care services platform focused on older adults. CenterWell includes primary care clinics, home health services and pharmacy services, with an emphasis on coordinated care, chronic-condition management and helping members receive care in lower-cost settings.

Founded in 1961 as a nursing-home company, Humana expanded into hospital operations before shifting its focus toward health insurance and related services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.